# Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System

> **NCT01733069** · — · COMPLETED · sponsor: **Gen-Probe, Incorporated** · enrollment: 1912 (actual)

## Conditions studied

- Chlamydia Trachomatis
- Neisseria Gonorrhoeae Infection

## Interventions

- **DEVICE:** APTIMA COMBO 2 Assay (AC2 Assay)

## Key facts

- **NCT ID:** NCT01733069
- **Lead sponsor:** Gen-Probe, Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 1912 (ACTUAL)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01733069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01733069, "Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT01733069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*